RSS Feed For (NASDAQ:GILD)

GILEAD SCIENCES (NASDAQ:GILD)

46.30 +0.21 (0.46%)
GILEAD SCIENCES (NASDAQ:GILD) Delayed :
Previous Close $46.09    52 Week High $52.29 
Open $46.57    52 Week Low $40.62 
Day High $47.00    P/E 16.42 
Day Low $46.05    EPS $2.82 
Volume 9,495,990       
More GILD Info: Chart SEC Filings Profile Historical Options

Gilead Sciences Inc. Summary

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life-threatening infectious diseases. The company markets its products in the United States, Australia, Austria, Belgium, Canada, France, Germany, Greece, Ireland, Italy, the Netherlands, New Zealand, Portugal, Spain, Switzerland, Turkey, and the United Kingdom ...more

Executives

John C. Martin - CEO

Links

http://www.gilead.com

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
YHOO 11 CVTX 9
NVAX 9 AMGN 8
AVII 8 SNDK 8
BCRX 7 AMLN 7
HEB 7 VICL 6
AMD 6 CAT 6
View All Friends, Peers and Foes

View All Major News StreetInsider.com Major News for GILD

Jan 26, 2010 05:24 PM Gilead Sciences (GILD) Reports Strong Q4 Results
Oct 20, 2009 04:09 PM Gilead Sciences (GILD) Tops Q3 EPS by 11c
Jul 21, 2009 04:07 PM Gilead Sciences (GILD) Tops Q2 Views
View All Major News

StreetInsider Reports on GILD by Category

View All Comments Comments on recent GILD articles

herpesfinder
on Feb 3, 2010
at 10:29 PM
herpes dating it;s said by stdloves.com half of HIVers died every yesr, right?
Article: Highlights From GILD's Q4 Conference Call: Q4 Crossed $2 Billion Mark for First Time in Company History
victor montenegro
on Jan 29, 2010
at 08:47 PM
gild the finest company under the sun is : "gild ".It's strong buy.By January 2012 will be $95.00 Victor Montenegro
Article: Form 4 GILEAD SCIENCES INC For: Jan 27 Filed by: Alton Gregg H
Hedgie
on Jan 6, 2010
at 05:59 PM
GILD Man, that Morgan Stanley analyst sure hates him some Gilead. He may or may not be right about the pipeline, but the share price already reflects his concerns and then some.
Article: Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)
khalil
on Jul 24, 2009
at 09:29 AM
atripla stop letting people die because a patent stops affordable drugs. healthcare is a right not a privilege as it is in Amerika.
Article: Gilead Sciences (GILD) Receives Notification of ANDA Filing for Atripla by Teva Pharma (TEVA)
natasa
on Jun 15, 2009
at 05:04 AM
Small business You are surviving the recession and you are waiting for the recovery. Now, while you wait for the recovery and the chance to once again make some money, take a look at these marketing recommendations and plan ahead, but also the main key for your small business on www.bizcloud.net If you are a buyer or seller of small businesses or some expert, you will find great value for your idea, business or maybe some business doubt!
Article: Top 10 News Items 6/8-6/12: Treasury Approves 10 Banks to Repay TARP; Yields Rising on Mixed Auction Results; Crude Cracks $70/Barrel
View All Comments

Comments on GILD


No comments are currently available.